Insider Trading Insights: NTRA Executives Sell Shares

Insider trading raises concerns as NTRA President sells shares. Solomon Moshkevich sold 1,632 shares, part of a larger trend of insider selling without any purchases. This activity may signal cautious outlook among insiders.

Date: 08-02-2025

AI Rating: 4

Insider Trading Activity
Recent transactions of $NTRA stock reveal a significant trend in insider trading activity. Solomon Moshkevich, the President, sold 1,632 shares valued at an estimated $290,120, representing 1.1% of his total shares in $NTRA. Notably, in a span of six months, there have been 171 sales by insiders with no purchases recorded. This heavy selling raises potential red flags for investors regarding insiders' confidence in the company's future performance.

Institutional Activity
Institutional investment behaviors depict a mixed response to $NTRA stock. In the recent quarter, 246 institutional investors have increased their positions, while 264 have decreased theirs. Significant moves include Price T Rowe Associates, which added 2,341,756 shares (up 442.8%), signaling a strong bullish position. Conversely, significant reductions by JPMorgan Chase and Fred Alger Management reflect a cautious stance among some investors.

Congressional Stock Trading
Interestingly, there has been minimal congressional trading activity with only one recorded purchase by Representative Josh Gottheimer for up to $15,000. This isolated purchase contrasts sharply with the insider sell-off trend, indicating a contrasting view on the company's resilience or potential upside.

In summary, the analyses of insider, institutional, and congressional trading indicate a cautious outlook on $NTRA, particularly due to the prevalent trend of insider selling.

Stocks: NTRA